Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Portage Biotech Inc

PRTG
3,96
-0,01 (-0,25%)
17 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/1/202512:12EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/1/202512:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/1/202511:00GLOBEPortage Biotech Announce Re-Launch of Adenosine Subsidiary..
19/12/202422:43EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
17/12/202413:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/12/202413:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/12/202413:00GLOBEPortage Biotech Announces Letter of Intent with Immunova for..
13/12/202422:35EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/12/202422:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202423:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/12/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202422:15GLOBEPortage Biotech Announces Receipt of Nasdaq Noncompliance..
05/12/202422:35EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/12/202422:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/11/202422:47EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
26/11/202422:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/11/202422:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/11/202422:05GLOBEPortage Biotech Reports Results for Fiscal Quarter Ended..
14/11/202422:26EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
04/10/202422:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/10/202422:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202403:18EDGAR2Form 144 - Report of proposed sale of securities
27/9/202422:28EDGAR2Form 144 - Report of proposed sale of securities
23/9/202415:41EDGAR2Form 144 - Report of proposed sale of securities
20/9/202417:25EDGAR2Form 144 - Report of proposed sale of securities
27/8/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/8/202414:00GLOBEPortage Biotech Reports Results for Fiscal Quarter Ended..
27/8/202412:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/8/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202414:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/8/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202413:00GLOBEPortage Biotech Reports Fiscal Year-Ended March 31, 2024..
14/8/202423:29EDGAR2Form 20-F - Annual and transition report of foreign private..
13/8/202414:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/8/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/8/202413:00GLOBEPortage Biotech Announces 1-for-20 Reverse Stock Split
01/8/202422:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/4/202414:01GLOBEPortage Biotech Announces Plans to Expand its Evaluation of..
26/3/202413:01GLOBEPortage Biotech Completes Monetization of Intensity..
08/3/202423:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/3/202423:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/2/202423:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202423:10GLOBEPortage Biotech Reports Results for Fiscal Quarter Ended..
18/1/202423:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 3,99 Min: 3,855 Max: 4,15
Chiusura: 3,97

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network